| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Principal Accounting Officer | Stock Option (Right to Buy) | 46.9K | Jan 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | Aug 14, 2025 | 0 | $0 | 3 | Aug 22, 2025 | Principal Accounting Officer |
| TCRX | TScan Therapeutics, Inc. | Jan 12, 2024 | 1 | $0 | 4 | Feb 11, 2025 | Vice President, Finance |
| TCRX | TScan Therapeutics, Inc. | Jul 21, 2023 | 1 | $0 | 4 | Jul 24, 2023 | Chief Accounting Officer |
| TCRX | TScan Therapeutics, Inc. | Jul 21, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Chief Accounting Officer |